Skip to content
healthcare.dev

Temozolomide

NDC 67877-539, Temozolomide, capsule, from Ascend Laboratories, LLC.

Product NDC
67877-539
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207658
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-539 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE100 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
67877-539-07678770539075 CAPSULE in 1 BOTTLE (67877-539-07)
67877-539-146787705391414 CAPSULE in 1 BOTTLE (67877-539-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/33d67bce-38ae-45fc-a858-d51167b0ecfd
  • NADAC price for package 67877053907

    GET /v1/drugs/nadac/67877053907
  • NADAC price for package 67877053914

    GET /v1/drugs/nadac/67877053914

Use it

Look up 67877-539 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-539 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-539. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.